Clinical comparison diagram showing exosome vesicle and PDRN DNA fragment pathways converging on fibroblast regeneration with patient selection decision tree

Exosomes vs PDRN: Choosing the Right Regenerative Injectable for Your Patient

Two of the most clinically significant injectable categories in modern aesthetic medicine — polynucleotides/PDRN and exosomes — are frequently compared by practitioners trying to determine which to offer, which to prioritise for specific patients, and whether there is clinical value in using both. The comparison is worth making carefully, because the two treatments operate through genuinely different mechanisms, have different evidence bases, suit different patient profiles in some respects, and produce their best outcomes in different clinical contexts.